Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
- Cell and Gene Therapy at a Turning Point January 30, 2026
- Sepsis Gap & Home Testing Growth: Interview with Kalorama Information’s Daniel Granderson January 9, 2026
- What Is the Size of the IVD Market in 2025? September 8, 2025
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Six Other Respiratory Conditions Healthcare Systems are Watching
The fast spread of COVID-19, a respiratory condition, has healthcare systems focused on other diseases that could spread using the same method. Kalorama Information’s Emerging Infectious Disease Diagnostics report: (https://kaloramainformation.com/product/emerging-infectious-disease-diagnostics-markets-and-trends/) details multiple types of viruses that are being tracked worldwide, many that have jumped from developing nations to developed ones. These are some of the […]
Coagulation Tests Find Use in COVID-19, New Anticoagulants
Coagulation is a complex process in which multiple enzymes and proteins regulate blood flow and clot formation. Coagulation (clot formation), fibrinolysis and platelet aggregation are a part of this process. Fibrinolysis refers to the breakup of blood clots. It is a normal body process that keeps naturally occurring blood clots from growing and causing problems. Anticoagulant drugs help prevent blood platelets from sticking or clumping together, reducing the likelihood that arteries will be blocked by a clot, leading to a stroke or heart attack.
Drug Discovery Outsourcing – COVID-19 has Mixed Effect
Drug discovery is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will actually yield products that achieve regulatory approval by the U.S. Food & Drug Administration (FDA) or other global regulatory agencies. The average drug can take 10+ years to progress from the discovery phase to the clinic, […]
Cell Therapy Market Reaches 3.8 BN; Cancer Treatments Dominate and COVID-19 Applications Explored
Cell therapy involves the modification of human cell which are used to replace or repair damaged tissues or cells. Two areas with growing development and commercialization include chimeric antigen receptor (CAR)-T therapies and stem cell therapies. According to a recent report from Kalorama Information, the global market for cell and gene therapy in 2020 is […]
More POC COVID-19 Tests Approved: BioFire, Mesa
The FDA approved BioFire FilmArray COVD-19 test, as well as Mesa Biotech’s Accula. Both can bring a COVID-19 diagnosis to the point of care where testing is most needed. BioFire’s Film Array has thousands of placements. Accula is a hand-held test.
POC Testing Joins “War” on COVID-19 with 45-Minute Cepheid Test
We projected in Kalorama’s mPOC market study that molecular point of care ( mPOC ) would lead the fight in meeting the demand for COVID-19 testing with accurate and fast results. Lab staff is at a premium, hospitals are taxed, and testing needs to happen where it can be useful to isolate patients. We suggested that […]
In Breaking Transmission Chain of COVID-19 and Other Diseases, Point-of-Care is Best Hope
Demand for testing has gone from a healthcare industry topic to a national crusade in weeks with the onset of COVID-19. High-throughput tests have been approved by the U.S. Food and Drug Administration (FDA) for use in the U.S. for the detection of SARS-CoV-2, the virus behind the disease. But for true intervention in doctors […]
COVID-19: A Vaccine Solution?
Not since the Swine Flu epidemic of 2009 has there been this amount of emphasis on vaccines and vaccine development. This new infectious disease threat with no anti-viral, nor vaccine is causing significant concern among healthcare providers, governments and the public. Last-resort measures such as school closings and curfews in place in the United States […]
White House COVID-19 Plan Contains Diagnostics Boost
A rapid scale-up of diagnostic testing for the novel coronavirus was the focus of a declaration of emergency by President Donald Trump in a March 13 press conference. The plan calls for sharply boosting the production of coronavirus test kits while also making tests available at a network of drive-through sites. In an address at the […]
Slower-Than-Expected Adoption of Molecular Point-of-Care, But Growth Comes from Consumables
Molecular point-of-care diagnostic solutions offer improvements in the sensitivity and specificity of existing near-patient and rapid tests while expanding the diagnostic capabilities at points of care, such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world, and are used to assess conditions or admit patients. The concept […]